Comparison of intravenous cocaethylene and cocaine in humans

被引:53
作者
Hart, CL
Jatlow, P
Sevarino, KA
McCance-Katz, EF
机构
[1] Yale Univ, Sch Med, Div Substance Abuse, Dept Psychiat, W Haven, CT 06516 USA
[2] Yale Univ, Sch Med, Div Substance Abuse, Dept Lab Med, W Haven, CT 06516 USA
关键词
cocaethylene; cocaine; alcohol; pharmacokinetic; human subject;
D O I
10.1007/s002139900363
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Cocaethylene is a pharmacologically active homolog and metabolite of cocaine, formed by transesterification of cocaine in the presence of ethanol. Here we relate findings from a randomized, placebo-controlled, double-blind study in which we examined the physiological and subjective effects and pharmacokinetics of IV administered cocaethylene in human volunteers using cocaine as a comparator. Methods: Cocaine-dependent participants randomly received one study drug, cocaethylene (0.25 or 0.5 mg/kg), cocaine (0.25 or 0.5 mg/kg), or placebo, during each experimental session which occurred on separate days. Results: Cocaethylene was less potent in elevating heart rate than equivalent doses of cocaine. Similar differences between cocaine and cocaethylene were found for subjective measures ("Cocaine High", "Rush", "Stimulated" and "Good Drug Effects"). All active drug conditions produced significant increases in systolic blood pressure relative to placebo, but no significant effect on diastolic blood pressure was observed. Cocaethylene demonstrated a slower clearance, larger volume of distribution and correspondingly longer elimination half-life than cocaine. Conclusion: The findings from this study confirm those of previous studies that show that cocaethylene has pharmacological properties in common with cocaine, but is less potent.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 38 条
[1]   ACUTE TOLERANCE TO COCAINE IN HUMANS [J].
AMBRE, JJ ;
BELKNAP, SM ;
NELSON, J ;
RUO, TI ;
SHIN, SG ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :1-8
[2]   SEROTONERGIC MECHANISMS OF COCAINE EFFECTS IN HUMANS [J].
ARONSON, SC ;
BLACK, JE ;
MCDOUGLE, CJ ;
SCANLEY, BE ;
JATLOW, P ;
KOSTEN, TR ;
HENINGER, GR ;
PRICE, LH .
PSYCHOPHARMACOLOGY, 1995, 119 (02) :179-185
[3]   Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence [J].
Bradberry, CW ;
Lee, T ;
Jatlow, P .
PSYCHOPHARMACOLOGY, 1999, 146 (01) :87-92
[4]   COCAINE AND COCAETHYLENE - MICRODIALYSIS COMPARISON OF BRAIN DRUG LEVELS AND EFFECTS ON DOPAMINE AND SEROTONIN [J].
BRADBERRY, CW ;
NOBILETTI, JB ;
ELSWORTH, JD ;
MURPHY, B ;
JATLOW, P ;
ROTH, RH .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (04) :1429-1435
[5]   SEROTONIN INVOLVEMENT IN COCAINE SENSITIZATION - CLUES FROM STUDIES WITH COCAINE ANALOGS [J].
ELSWORTH, JD ;
TAYLOR, JR ;
JATLOW, P ;
ROTH, RH .
DRUG DEVELOPMENT RESEARCH, 1993, 30 (03) :189-200
[6]  
FARRE M, 1993, J PHARMACOL EXP THER, V266, P1364
[7]  
Farre M, 1997, J PHARMACOL EXP THER, V283, P164
[8]   TOBACCO DEPENDENCE AND THE NICOTINE PATCH - CLINICAL GUIDELINES FOR EFFECTIVE USE [J].
FIORE, MC ;
JORENBY, DE ;
BAKER, TB ;
KENFORD, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (19) :2687-2694
[9]  
First S., 1995, BIOMETRICS RES DEP
[10]   A COMPARISON OF THE SUBJECTIVE AND CARDIOVASCULAR EFFECTS OF COCAINE AND LIDOCAINE IN HUMANS [J].
FISCHMAN, MW ;
SCHUSTER, CR ;
HATANO, Y .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 (01) :123-127